Steven Cohen’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
Steven Cohen's PRME Position: Q3 2026 in Review
Steven Cohen increased its Prime Medicine (PRME) stake by 41% in Q3 2026, buying an estimated $731K and bringing the position to 753,741 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2327.
Steven Cohen first reported a position in PRME in Q4 2024 and has held it in 4 quarters since. 186 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- Steven Cohen held 753,741 shares of Prime Medicine worth $2.3M as of Q3 2026.
- Steven Cohen bought 220,188 Prime Medicine shares in Q3 2026, an estimated $731K.
- Prime Medicine made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2327 holding.
- Steven Cohen first reported a position in Prime Medicine in Q4 2024 and has held it in 4 quarters since.
- 186 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.